3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Recruiting
2
Completed
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Hyperthermia
10
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Breast Neoplasms
1
Interventions
Capecitabine
29
Oxaliplatin
28
Fluorouracil
16
Radiotherapy
15
Drug Therapy
11
Leucovorin
10
Bevacizumab
10
Surgical Procedures, Operative
9
Chemoradiotherapy
8
Radiation
7
sintilimab
6
Consolidation Chemotherapy
6
tislelizumab
5
spartalizumab
5
Specimen Handling
5
Irinotecan
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
XELOX
4
Neoadjuvant Therapy
4
Endoscopy
4
Cetuximab
4
Biopsy
4
toripalimab
3
pembrolizumab
3
irinotecan sucrosofate
3
X-Rays
3
Radiotherapy, Intensity-Modulated
3
Proctectomy
3
Mastectomy, Segmental
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Rectal Neoplasms
×
Diathermy
×
Clear all
NCT07372300
2026-01-28
mEHT
Dalin Tzu Chi General Hospital
Phase 3
Recruiting
126 enrolled
NCT06831981
2025-02-18
ARO 2024-13
University Hospital Tuebingen
Phase NA
Recruiting
264 enrolled